Amneal Has Begun Supplying OTC Naloxone Hydrochloride Nasal Spray To U.S. Retail Pharmacies And The State Of California
Portfolio Pulse from Benzinga Newsdesk
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) has started supplying its OTC Naloxone Hydrochloride Nasal Spray to U.S. retail pharmacies and the State of California. The company is also working to expand access to other states and municipalities.
May 22, 2024 | 8:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amneal Pharmaceuticals has started supplying its OTC Naloxone Hydrochloride Nasal Spray to U.S. retail pharmacies and the State of California, with plans to expand to other states and municipalities.
The distribution of OTC Naloxone Nasal Spray to retail pharmacies and the State of California is likely to boost Amneal's revenues and market presence. The company's efforts to expand access to other states and municipalities further enhance its growth prospects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100